TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage produc…
Biotechnology
US, Boston [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared TransCode Therapeutics, Inc. (RNAZ) to it's peer group.
Peer Group
Loading...